In IHD, CD4 + T cells are pivotal players of immunomodulation [117, 118]; importantly, pro-inflammatory effector T cells (Teff) expand in IHD [119], while numbers of regulatory T cells (Tregs) decrease following MI [120, 121]. This evidence concerns the gene CD4 and myocardial ischemia.